Recent Finacing
Recent Raise
CERo Therapeutics develops engineered immune cells using the CER‑T platform, combining innate and adaptive signaling to address solid tumors, and collaborates with Lyell while advancing preclinical and clinical programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Cero Therapeutics.
